Skip to main content
. Author manuscript; available in PMC: 2023 Apr 3.
Published in final edited form as: Matern Child Health J. 2018 Feb;22(2):237–246. doi: 10.1007/s10995-017-2395-8

Table 6.

Hypertension and antihypertensive medication use and risk of SGA, by maternal age, National Birth Defects Prevention Study, 1997-2011.a

graphic file with name nihms-1874068-t0002.jpg
a

Table includes results of two separate comparisons: 1. Untreated hypertensive mothers vs. untreated normotensive mothers, by age; and 2. Treated hypertensive mothers vs. untreated normotensive mothers, by age. Reference group for all comparisons is untreated normotensive mothers ages 20-34 years.

b

Adjusted for maternal race/ethnicity, maternal prepregnancy BMI, late pregnancy smoking, early pregnancy folic acid supplement use, and study site.